Pharmafile Logo
Pharmafocus logo
Advanced Search
Actos image

Analysis finds no Actos bladder cancer link

December 8, 2014
Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2

A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …

News
People image

The valuable world of Real World Evidence

December 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, data, martin goldman, real world evidence, transparency

What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …

Feature
james_christie_abpi

ABPI appoints first manufacturing director

December 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, James Christie

The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …

Appointment
Bayer image

Bayer files haemophilia drug in EU

December 5, 2014
Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate

Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …

News
GSK image

GSK cancels sale of established products

December 5, 2014
Medical Communications, Sales and Marketing FDA, GSK, Paxil, Seroxat, Zantac, bribery, cuts, imitrex

GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …

News
Sanofi image

Merck sells manufacturing facility to Sanofi

December 5, 2014
Manufacturing and Production, Sales and Marketing Merck, Merial, Puerto Rico, Sanofi, manufacturing

Sanofi’s animal health unit Merial is acquiring Merck’s manufacturing facility in Barceloneta, Puerto Rico. The proposed transaction requires the nod …

News
Ranbaxy image

Ranbaxy launches J&J biosimilar in India

December 5, 2014
Manufacturing and Production, Sales and Marketing CHMP, FDA, India, J&J, JJ, Ranbaxy, Remicade, nlem, nppa

Ranbaxy has launched the first biosimilar of Johnson & Johnson’s Remicade (infliximab) in India, marking the firm’s entry into monoclonal …

News
Amgen image

Speedy FDA nod for Amgen leukaemia drug

December 5, 2014
Research and Development, Sales and Marketing B-cell lymphoblasts, FDA, Kyprolis, blinatumomab, blincyto, leukaemia

The FDA has approved Amgen’s Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukaemia (B-cell ALL). …

News
screen_shot_2014-12-05_at_08

IDEA Pharma appoints two vice presidents

December 5, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90px, IDEA Pharma, kelly, weston

IDEA Pharma has hired both Samantha Weston and Paul Kelly as vice presidents in business development to boost the company’s …

Appointment
Actavis image

Actavis to axe 200 jobs

December 4, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Forest, GSK, Warner Chilcott, corona, stevenage

Actavis is set to cut 200 jobs in the US just weeks after buying Allergan for $66 billion. The lay-offs …

News

Government seeks stakeholder consultation over NICE

December 4, 2014
Sales and Marketing ABPI, NHS, NICE, UK, emms, freeman, government, ndpb

NICE stakeholders are being asked for their views on its future as part of the government’s ongoing review into the …

News

Astellas ‘app challenge’ aims to inspire future talent

December 4, 2014
Medical Communications, Sales and Marketing Astellas, CDF, CRUK, Ken Jones, app, my jar, stem

Last week Astellas announced the winner of its Science, Technology, Engineering, and Mathematics (STEM) skills Innovation Challenge competition at an …

News
Merck image

Merck Ebola vaccine shows promise

December 4, 2014
Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics

Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …

News
andy-powrie-smith

ABPI director jumps ship to EFPIA

December 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, Whitehead, andrew powrie-smith, andrew-powrie-smith

ABPI director Andrew Powrie-Smith is leaving the body to join The European Federation of Pharmaceutical Industries and Associations (EFPIA) as …

Appointment
GSK image

GSK confirms hundreds of US job cuts

December 3, 2014
Medical Communications, Research and Development, Sales and Marketing Advair, GSK, Parexel, RTP, anoro, breo, job cuts, respiratory

GlaxoSmithKline has finally confirmed the rumours that it is cutting hundreds of US jobs as the UK firm struggles to …

News
Osborne and co image

UK budget sees R&D tax credits rise

December 3, 2014
Sales and Marketing Budget, Cameron, George Osborne, NHS, Whitehead, life sciences

Chancellor George Osborne has delivered the government’s 2014 Autumn Statement to the Commons which includes news of an increase in …

News
Evotec image

Evotec and Sanofi enter pre-clinical deal

December 3, 2014
Research and Development, Sales and Marketing DiaPep277, Evotec, Sanofi, oncology, priftin, toulouse

Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …

News
Sepha award

Packaging machinery specialist, Sepha Ltd, Wins National Award for Excellence in Innovation

December 3, 2014

The Northern Ireland-based packaging machinery manufacturer, Sepha Ltd. has won the award for Excellence in Innovation from the UK Chamber …

News
Press release

NICE recommends test to reduce antibiotic use

December 3, 2014
Sales and Marketing Antibiotics, GPs, NICE, UK, doctors, icl, pneumonia

NICE guidelines say GPs should use point of care blood tests to assess which patients to prescribe antibiotics for bacterial …

News
Novartis image

Novartis flu vaccine cleared following safety probe

December 3, 2014
Sales and Marketing GSK, Novartis, Vaccine, flu, fluad

The Italian drugs safety agency has cleared the Novartis influenza vaccine Fluad, after an investigation found the vaccine was not …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026